{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-25-000010","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.645332+00:00","generated_at":"2026-05-16T12:30:15.453847+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspira Women's Health signs 5-year lab services pact with Mayo Clinic","bullets":["Aspira will provide Ova1Plus and OvaWatch tests to Mayo on a non-exclusive, as-requested basis for clinical purposes.","Initial term of 5 years, automatic annual renewals; either party may terminate with 90 days' notice.","Mayo to list tests in its catalog, handle ordering, results delivery, and billing; Aspira invoices Mayo.","Fees fixed during initial term absent mutual adjustment; agreement not yet filed due to redactions."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-25-000010","json":"https://secwatch.observer/filing/0000926617-25-000010.json","markdown":"https://secwatch.observer/filing/0000926617-25-000010.md","text":"https://secwatch.observer/filing/0000926617-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661725000010/0000926617-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661725000010/awhl-20251216x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:30:15.453847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}